Figure 1 Patterns of joint and organ involvement in rheumatic disease

Slides:

Advertisements

Similar presentations

Welcome to the Arthritis Foundation’s Introduction To Arthritis!

Advertisements

Osteoarthritis. Knee osteoarthritis Osteoarthritis.

Nomenclature and classification of rheumatic diseases INFLAMMATORY JOINT DISEASES Rheumatoid arthritis Diseases of connective tissue ( SLE, Antiphospholipid.

4. Rheumatologic conditions

Chapter 15 Lesson 15.2 Joint (articulation) Bursae Arthritis Ankylosing spondylitis Gouty arthritis Osteoarthritis (OA) Rheumatoid arthritis (RA) Bunion.

Figure 3 The induction of anti-DNA antibodies by bacterial DNA

Figure 1 Lymphocytes during the disease

Autoimmune liver disease, autoimmunity and liver transplantation

Figure 5 Involvement of B cells in SLE

Figure 1 Historical evolution of the clinical classification and

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Enthesitis versus synovitis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 2 Heat map of targeted therapies in autoimmune diseases

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Copyright © 2016 McGraw-Hill Education. All rights reserved.

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Rheumatic Disorders.

Figure 3 Simplified EULAR and GRAPPA

Figure 2 Simplified EULAR and GRAPPA

Figure 4 Antinuclear antibodies and disease activity in SLE

Figure 3 Transcriptome studies performed in the target

Figure 2 Shared genetic loci in systemic autoimmune diseases

Figure 3 Nucleic acid sensors in SLE

Outcomes of coronary artery bypass grafting in patients with inflammatory rheumatic diseases: An 11-year nationwide cohort study Chao-Han Lai, MD, PhD,

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Strategies to achieve therapeutic inhibition of IL-1

Figure 4 Approaches to targeting inhibitory immune receptors

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Overlap of associated loci among five rheumatic diseases

Nat. Rev. Rheumatol. doi: /nrrheum

Tom Pettersson, M.D., Matti Klockars, M.D., Teddy Weber, M.D.

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Statistical approaches for the analysis of metabolomic data

Figure 3 Bone marrow lesions in osteoarthritis

Figure 3 Multi-hit model for autoimmune diseases

Figure 1 Simplified EULAR and GRAPPA

Main fields of interest.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Emerging hallmarks of T cells in rheumatoid arthritis

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Treat to target, remission and low disease activity in SLE

Figure 1 The current model of the pathogenesis of SLE

Engineering a New Mouse Model for Vitiligo

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Reproductive health in patients with rheumatic diseases

Figure 1 Principles for the diagnosis and management of osteoarthritis

Updates in RA, PsA, and Biosimilars

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Phenotypes of osteoarthritis

Relationships between the baseline disease activity scores and scintigraphic sum scores for the patients with RA, pSpA and axSpA. Relationships between.

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 The main effects of adipokines on bone remodelling in osteoarthritis Figure 2 | The main effects of adipokines on bone remodelling in osteoarthritis.

Patient-reported adherence towards different IMID treatments in RA (A), PsA (B) or AS (C). Patient-reported adherence towards different IMID treatments.

Performance characteristics for multivariate assay SLE panel.

Nat. Rev. Rheumatol. doi: /nrrheum

Heterogeneity of TCRβ repertoire in autoimmune diseases.

Ultrasonographic characteristics and synovitis pattern of patients with inflammatory bowel disease (IBD) with onset of peripheral arthritis under tumour.

Cardiovascular disease risk assessment capture rates in the NOCAR project, evaluated across diagnosis groups and participating centre. Cardiovascular disease.

Anti-CarALB antibody prevalence and levels in RA and other CTD

Presentation transcript:

Figure 1 Patterns of joint and organ involvement in rheumatic disease Figure 1 | Patterns of joint and organ involvement in rheumatic disease. Even though rheumatic diseases can present with variable symptoms in individual patients, characteristic patterns of joint and organ involvement are distinguishable between rheumatic diseases. AS, ankylosing spondylitis; OA, osteoarthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, systemic sclerosis. Ospelt, C. & Frank-Bertoncelj, M. (2017) Why location matters — site-specific factors in rheumatic diseases Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.96